BibTex RIS Kaynak Göster

Çocukluk Çağında Guillain-Barré Sendromu

Yıl 2015, , 89 - 98, 01.07.2015

Muhammet Ali Varkal Edibe Yıldız İsmail Yıldız Nur Aydınlı Emin Ünüvar

https://doi.org/10.5222/j.child.2015.089

Öz

Guillain-Barré Sendromu tüm yaşlarda görülebilen akut inflamatuvar bir polinöropatidir. Semptomlar genellikle alt ekstremitelerden başlayarak yukarı doğru ilerler. Simetrik kas güçsüzlüğü ve derin tendon reflekslerinin kaybı ile karakterizedir. Solunum yetmezliği nedeniyle bazen ölüm- cül olabilmektedir. Tanı, klinik ve laboratuvar testlerle konur. Guillain-Barré Sendromu tedavi edilebilir bir hasta- lıktır. Gelişmiş tedavi yöntemleri ile hastalarda tam bir iyileşme görülebilmektedir. En önemli ölüm nedeni solu- num yetmezliği ve otonom tutuluma bağlı ciddi aritmilerdir. İlerleyici bir kliniği olması nedeniyle erken tanı ve tedavi prognozu olumlu etkilemektedir. Tedavide intravenöz immunglobulin ve plazma değişimi kullanılır. Rehabilitasyonun tam düzelmede önemi büyüktür

Anahtar Kelimeler

Guillain-Barré sendromu polinöropati AIDP AMAN AMSAN

Kaynakça

  • lee JH, Sung ıY, rew ıS. Clinical presentation and prognosis of childhood Guillain-Barré syndrome. J Paediatr Child Health 2008;44:449-54.
  • https://doi.org/10.1111/j.1440-1754.2008.01325.x2.
  • Sarnat HB. Chapter 615 Guillain-Barré Syndrome. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF (Eds) Nelson Textbook of Pediatrics. 18th edition. Philadelphia: WB. Saunders Company, 2007: 2565-6.
  • Agrawal S, Peake d, Whitehouse WP. Management of children with Guillain-Barré Syndrome. Arch Dis Child Educ Pract Ed 2007;92:161-8.
  • https://doi.org/10.1136/adc.2004.065706
  • ryan MM. Guillain-Barré Syndrome in childhood. J Paediatr. Child Health 2005;41:237-41.
  • https://doi.org/10.1111/j.1440-1754.2005.00602.x
  • rabie M, Nevo Y. Childhood acute and chronic immune-mediated polyradiculoneuropathies. European Journal of Paediatric Neurology 2009;13:209-18.
  • https://doi.org/10.1016/j.ejpn.2008.04.009
  • Hughes rA, Bouche P, Cornblath dr, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflam- matory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:326-32.
  • https://doi.org/10.1111/j.1468-1331.2006.01278.x
  • Visser lH, van der Meche FGA, Meulstee J, et al. Cytomegalovirus infection and Guillain-Barré syndro- me: the clinical, electrophysiologic and prognostic features. Neurology 1996;47:668-73.
  • https://doi.org/10.1212/WNL.47.3.668
  • Hughes rAC, Cornblath dr. Guillain–Barré syndro- me. Lancet 2005;366:1653–66.
  • https://doi.org/10.1016/S0140-6736(05)67665-9
  • Paradiso G, Tripoli J, Galicchio S, Fejerman N. Epidemiological, clinical, and electrodiagnostic fin- dings in childhood Guillain-Barré syndrome: a reappra- isal. Ann Neurol 1999;46:701-7.
  • https://doi.org/10.1002/1531-8249(199911)46:5< 701::AID-ANA4>3.0.CO;2-7
  • Buompadre MC, Ga’n˜ ez lA, Miranda M, Arroyo HA. Unusual variants of Guillain–Barré syndrome in infancy. Rev Neurol 2006;42:85–90.
  • Winer JB. Guillain-Barré syndrome. Clinical review. BMJ 2008;337:227-31.
  • https://doi.org/10.1136/bmj.a671
  • Ammache z, Afifi Ak, Brown Ck, kimura J. Childhood Guillain-Barré syndrome: Clinical and electrophysiologic features predictive of outcome. J Child Neurol 2001;16:477.
  • Asbury Ak. New concepts of Guillain–Barré Syndrome. J Child Neurol 2000;15:183-91.
  • https://doi.org/10.1177/088307380001500308
  • rantala H, Uhari M, Niemela M. Occurrence, clini- cal manifestations, and prognosis of Guillain-Barré syndrome. Arch Dis Child 1991;66:706-9.
  • https://doi.org/10.1136/adc.66.6.706
  • Bradshaw dY, Jones Hr Jr. Guillain-Barré syndrome in children: Clinical course, electrodiagnosis, and prog- nosis. Muscle Nerve 1992;15:500-6.
  • https://doi.org/10.1002/mus.880150415
  • Jacops BC, Van doorn PA, Groeneveld JH, et al. Cytomegalovirus infection and anti-GM2 antibodys in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1997;62:641-3.
  • https://doi.org/10.1136/jnnp.62.6.641
  • rhodes kM and Tattersfield AE. Guillain-Barré syndrome associated with Campylobacter jejuni infec- tion. Br Med J 1982;285:173-4.
  • https://doi.org/10.1136/bmj.285.6336.173
  • ırving N, Ban MA, Tony H. Campylobacter species and Guillain-Barré syndrome clinic. Microbiol Reviews 1998;11:555-67.
  • Ho TW, Mishu B, li CY, Gao CY, Cornblath dr, Griffin JW, et al. Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain A Journal of Neurology 1995;118(3):597-605.
  • https://doi.org/10.1093/brain/118.3.597
  • Asbury Ak, Cornblath dr. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27:21-4.
  • https://doi.org/10.1002/ana.410270707
  • knebusch M, Strassburg HM, reiners k. Acute transverse myelitis in childhood: Nine cases and review of the literature. Dev Med Child Neurol 1998;40:631-9.
  • https://doi.org/10.1111/j.1469-8749.1998.tb15430.x
  • Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barré syndrome. Arch Neurol 2001;58:913-7.
  • https://doi.org/10.1001/archneur.58.6.913
  • Hiraga A, kuwabara S, Ogawara k, et al. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain–Barré syndrome. Neurology 2005;64: 856-60.
  • https://doi.org/10.1212/01.WNL.0000153071.71335.E9
  • Coşkun A, kumandaş S, Paç A, et al. Childhood Guillain–Barré syndrome. MR imaging in diagnosis and follow-up. Acta Radiol 2003;44:230-5.
  • https://doi.org/10.1034/j.1600-0455.2003.00023.x
  • Sladky JT. Guillain-Barré syndrome in children. J Child Neurol 2004;19:191-200.
  • Hughes rA, Wijdicks EF, Benson E, et al. Supportive care for patients with Guillain–Barré syndrome. Multidisciplinary Consensus Group. Arch Neurol 2005;62:1194-8.
  • https://doi.org/10.1001/archneur.62.8.1194
  • Wiffen PJ, McQuay HJ, Edwards JE, Moore rA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005;3: CD005452.
  • https://doi.org/10.1002/14651858.cd005452
  • korinthenberg r, Schessl J, kirschner J, Monting JS. Intravenously administered immunoglobulin in the treatment of childhood Guillain–Barré syndrome: a randomized trial. Pediatrics 2005;116:8-14.
  • https://doi.org/10.1542/peds.2004-1324
  • Hughes rA, Wijdicks EF, Barohn r, et al. Practice parameter: immunotherapy for Guillain-Barré syndro- me: report of the Quality Standards Subcommittee of the American Academy of Neurology. Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003;61:736-40.
  • https://doi.org/10.1212/WNL.61.6.736
  • Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain- Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Trial Group. Lancet 1997;349:225-30.
  • https://doi.org/10.1016/S0140-6736(96)09095-2
  • korinthenberg r, Schessl J, kirschner J, Schulte Mönting J. İntravenously administered immunoglobu- lin in the treatment of childhood Guillain-Barré syndro- me: a randomized trial. Pediatrics 2005;116:8-14.
  • https://doi.org/10.1542/peds.2004-1324
  • Epstein MA, Sladky JT. The role of plasmapheresis in childhood Guillain–Barré syndrome. Ann Neurol 1990; 28: 65–9.
  • https://doi.org/10.1002/ana.410280112
  • Guillain-Barré Syndrome Steroid Trial Group. Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet 1993;341-587.
  • Pithadia AB, kakadia N. Guillain-Barré syndrome. Pharmacological Reports 2010; 62:220-32.
  • https://doi.org/10.1016/S1734-1140(10)70261-9

Guillain-Barré Syndrome in Childhood

Yıl 2015, , 89 - 98, 01.07.2015

Muhammet Ali Varkal Edibe Yıldız İsmail Yıldız Nur Aydınlı Emin Ünüvar

https://doi.org/10.5222/j.child.2015.089

Öz

Guillain-Barré Syndrome is an acute inflammatory polyne- uropathy that can be seen at all ages. Commonly symptoms originate in the lower extremities and progress upward. The disease characterizes by symmetrical muscle weakness and loss of deep tendon reflexes. Sometimes it becomes fatal due to respiratory failure. Diagnosis is made with clinical and laboratory tests. Guillain-Barré Syndrome is a treatable disease. Full recovery can be seen in patients with advanced treatment methods. The most important cause of death is respiratory failure and serious arrhythmi- as due to autonomic involvement. Because of its progressi- ve clinical course, early diagnosis and treatment effect prognosis favourably. Intraveneus immunglobulin and plasma exchange are used in the treatment. Rehabilitation is greatly important for full recovery

Anahtar Kelimeler

Guillain-Barré syndrome polyneuropathy AIDP AMAN AMSAN

Kaynakça

  • lee JH, Sung ıY, rew ıS. Clinical presentation and prognosis of childhood Guillain-Barré syndrome. J Paediatr Child Health 2008;44:449-54.
  • https://doi.org/10.1111/j.1440-1754.2008.01325.x2.
  • Sarnat HB. Chapter 615 Guillain-Barré Syndrome. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF (Eds) Nelson Textbook of Pediatrics. 18th edition. Philadelphia: WB. Saunders Company, 2007: 2565-6.
  • Agrawal S, Peake d, Whitehouse WP. Management of children with Guillain-Barré Syndrome. Arch Dis Child Educ Pract Ed 2007;92:161-8.
  • https://doi.org/10.1136/adc.2004.065706
  • ryan MM. Guillain-Barré Syndrome in childhood. J Paediatr. Child Health 2005;41:237-41.
  • https://doi.org/10.1111/j.1440-1754.2005.00602.x
  • rabie M, Nevo Y. Childhood acute and chronic immune-mediated polyradiculoneuropathies. European Journal of Paediatric Neurology 2009;13:209-18.
  • https://doi.org/10.1016/j.ejpn.2008.04.009
  • Hughes rA, Bouche P, Cornblath dr, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflam- matory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006;13:326-32.
  • https://doi.org/10.1111/j.1468-1331.2006.01278.x
  • Visser lH, van der Meche FGA, Meulstee J, et al. Cytomegalovirus infection and Guillain-Barré syndro- me: the clinical, electrophysiologic and prognostic features. Neurology 1996;47:668-73.
  • https://doi.org/10.1212/WNL.47.3.668
  • Hughes rAC, Cornblath dr. Guillain–Barré syndro- me. Lancet 2005;366:1653–66.
  • https://doi.org/10.1016/S0140-6736(05)67665-9
  • Paradiso G, Tripoli J, Galicchio S, Fejerman N. Epidemiological, clinical, and electrodiagnostic fin- dings in childhood Guillain-Barré syndrome: a reappra- isal. Ann Neurol 1999;46:701-7.
  • https://doi.org/10.1002/1531-8249(199911)46:5< 701::AID-ANA4>3.0.CO;2-7
  • Buompadre MC, Ga’n˜ ez lA, Miranda M, Arroyo HA. Unusual variants of Guillain–Barré syndrome in infancy. Rev Neurol 2006;42:85–90.
  • Winer JB. Guillain-Barré syndrome. Clinical review. BMJ 2008;337:227-31.
  • https://doi.org/10.1136/bmj.a671
  • Ammache z, Afifi Ak, Brown Ck, kimura J. Childhood Guillain-Barré syndrome: Clinical and electrophysiologic features predictive of outcome. J Child Neurol 2001;16:477.
  • Asbury Ak. New concepts of Guillain–Barré Syndrome. J Child Neurol 2000;15:183-91.
  • https://doi.org/10.1177/088307380001500308
  • rantala H, Uhari M, Niemela M. Occurrence, clini- cal manifestations, and prognosis of Guillain-Barré syndrome. Arch Dis Child 1991;66:706-9.
  • https://doi.org/10.1136/adc.66.6.706
  • Bradshaw dY, Jones Hr Jr. Guillain-Barré syndrome in children: Clinical course, electrodiagnosis, and prog- nosis. Muscle Nerve 1992;15:500-6.
  • https://doi.org/10.1002/mus.880150415
  • Jacops BC, Van doorn PA, Groeneveld JH, et al. Cytomegalovirus infection and anti-GM2 antibodys in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1997;62:641-3.
  • https://doi.org/10.1136/jnnp.62.6.641
  • rhodes kM and Tattersfield AE. Guillain-Barré syndrome associated with Campylobacter jejuni infec- tion. Br Med J 1982;285:173-4.
  • https://doi.org/10.1136/bmj.285.6336.173
  • ırving N, Ban MA, Tony H. Campylobacter species and Guillain-Barré syndrome clinic. Microbiol Reviews 1998;11:555-67.
  • Ho TW, Mishu B, li CY, Gao CY, Cornblath dr, Griffin JW, et al. Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain A Journal of Neurology 1995;118(3):597-605.
  • https://doi.org/10.1093/brain/118.3.597
  • Asbury Ak, Cornblath dr. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27:21-4.
  • https://doi.org/10.1002/ana.410270707
  • knebusch M, Strassburg HM, reiners k. Acute transverse myelitis in childhood: Nine cases and review of the literature. Dev Med Child Neurol 1998;40:631-9.
  • https://doi.org/10.1111/j.1469-8749.1998.tb15430.x
  • Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barré syndrome. Arch Neurol 2001;58:913-7.
  • https://doi.org/10.1001/archneur.58.6.913
  • Hiraga A, kuwabara S, Ogawara k, et al. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain–Barré syndrome. Neurology 2005;64: 856-60.
  • https://doi.org/10.1212/01.WNL.0000153071.71335.E9
  • Coşkun A, kumandaş S, Paç A, et al. Childhood Guillain–Barré syndrome. MR imaging in diagnosis and follow-up. Acta Radiol 2003;44:230-5.
  • https://doi.org/10.1034/j.1600-0455.2003.00023.x
  • Sladky JT. Guillain-Barré syndrome in children. J Child Neurol 2004;19:191-200.
  • Hughes rA, Wijdicks EF, Benson E, et al. Supportive care for patients with Guillain–Barré syndrome. Multidisciplinary Consensus Group. Arch Neurol 2005;62:1194-8.
  • https://doi.org/10.1001/archneur.62.8.1194
  • Wiffen PJ, McQuay HJ, Edwards JE, Moore rA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005;3: CD005452.
  • https://doi.org/10.1002/14651858.cd005452
  • korinthenberg r, Schessl J, kirschner J, Monting JS. Intravenously administered immunoglobulin in the treatment of childhood Guillain–Barré syndrome: a randomized trial. Pediatrics 2005;116:8-14.
  • https://doi.org/10.1542/peds.2004-1324
  • Hughes rA, Wijdicks EF, Barohn r, et al. Practice parameter: immunotherapy for Guillain-Barré syndro- me: report of the Quality Standards Subcommittee of the American Academy of Neurology. Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003;61:736-40.
  • https://doi.org/10.1212/WNL.61.6.736
  • Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain- Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Trial Group. Lancet 1997;349:225-30.
  • https://doi.org/10.1016/S0140-6736(96)09095-2
  • korinthenberg r, Schessl J, kirschner J, Schulte Mönting J. İntravenously administered immunoglobu- lin in the treatment of childhood Guillain-Barré syndro- me: a randomized trial. Pediatrics 2005;116:8-14.
  • https://doi.org/10.1542/peds.2004-1324
  • Epstein MA, Sladky JT. The role of plasmapheresis in childhood Guillain–Barré syndrome. Ann Neurol 1990; 28: 65–9.
  • https://doi.org/10.1002/ana.410280112
  • Guillain-Barré Syndrome Steroid Trial Group. Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet 1993;341-587.
  • Pithadia AB, kakadia N. Guillain-Barré syndrome. Pharmacological Reports 2010; 62:220-32.
  • https://doi.org/10.1016/S1734-1140(10)70261-9
Toplam 62 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Araştırma Makaleleri
Yazarlar

Muhammet Ali Varkal Bu kişi benim

Edibe Yıldız Bu kişi benim

İsmail Yıldız Bu kişi benim

Nur Aydınlı Bu kişi benim

Emin Ünüvar Bu kişi benim

Yayımlanma Tarihi 1 Temmuz 2015
Yayımlandığı Sayı Yıl 2015

Kaynak Göster

APA Varkal, M. A., Yıldız, E., Yıldız, İ., Aydınlı, N., vd. (2015). Çocukluk Çağında Guillain-Barré Sendromu. Çocuk Dergisi, 15(3), 89-98. https://doi.org/10.5222/j.child.2015.089
AMA Varkal MA, Yıldız E, Yıldız İ, Aydınlı N, Ünüvar E. Çocukluk Çağında Guillain-Barré Sendromu. Çocuk Dergisi. Temmuz 2015;15(3):89-98. doi:10.5222/j.child.2015.089
Chicago Varkal, Muhammet Ali, Edibe Yıldız, İsmail Yıldız, Nur Aydınlı, ve Emin Ünüvar. “Çocukluk Çağında Guillain-Barré Sendromu”. Çocuk Dergisi 15, sy. 3 (Temmuz 2015): 89-98. https://doi.org/10.5222/j.child.2015.089.
EndNote Varkal MA, Yıldız E, Yıldız İ, Aydınlı N, Ünüvar E (01 Temmuz 2015) Çocukluk Çağında Guillain-Barré Sendromu. Çocuk Dergisi 15 3 89–98.
IEEE M. A. Varkal, E. Yıldız, İ. Yıldız, N. Aydınlı, ve E. Ünüvar, “Çocukluk Çağında Guillain-Barré Sendromu”, Çocuk Dergisi, c. 15, sy. 3, ss. 89–98, 2015, doi: 10.5222/j.child.2015.089.
ISNAD Varkal, Muhammet Ali vd. “Çocukluk Çağında Guillain-Barré Sendromu”. Çocuk Dergisi 15/3 (Temmuz 2015), 89-98. https://doi.org/10.5222/j.child.2015.089.
JAMA Varkal MA, Yıldız E, Yıldız İ, Aydınlı N, Ünüvar E. Çocukluk Çağında Guillain-Barré Sendromu. Çocuk Dergisi. 2015;15:89–98.
MLA Varkal, Muhammet Ali vd. “Çocukluk Çağında Guillain-Barré Sendromu”. Çocuk Dergisi, c. 15, sy. 3, 2015, ss. 89-98, doi:10.5222/j.child.2015.089.
Vancouver Varkal MA, Yıldız E, Yıldız İ, Aydınlı N, Ünüvar E. Çocukluk Çağında Guillain-Barré Sendromu. Çocuk Dergisi. 2015;15(3):89-98.